Diabetes Mellitus, Type 2 Clinical Trial
— ENHANCEDOfficial title:
diEtitiaNs Helping pAtieNts CarE for Diabetes (ENHANCED)
| NCT number | NCT02980978 |
| Other study ID # | ENHANCED |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | April 2016 |
| Est. completion date | November 13, 2018 |
| Verified date | May 2019 |
| Source | Minneapolis Heart Institute Foundation |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study aims to randomly assign individuals with type 2 diabetes into the ENHANCED
randomized control trial. The study is being conducted by the Minneapolis Heart Institute
Foundation (MHIF) and will have two study sites 1) Hutchinson Health and 2) New Ulm Medical
Center. The study is primarily funded through the Academy of Nutrition and Dietetics (AND).
The study will examine the impact of a registered dietitian-led, primary care integrated,
telemedicine program on diabetes care measures (the 'D5') over one year as compared to usual
care. The D5 goals include: blood pressure <140/90 mmHg, taking a statin as appropriate, A1c
<8%, not using tobacco and taking an aspirin as appropriate.
| Status | Completed |
| Enrollment | 118 |
| Est. completion date | November 13, 2018 |
| Est. primary completion date | December 13, 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 40 Years to 75 Years |
| Eligibility |
Inclusion Criteria: 1. Diagnosis of Type 2 Diabetes 2. Individuals who are not meeting 3 or more D5 goals, 3. Have had a visit with a provider within the last 2 years Exclusion Criteria: 1. Type 1 Diabetes 2. Chronic kidney disease (GFR <30) 3. HIV 4. Institutional residence 5. Major cognitive or language barrier (as determined by program enrollment staff) 6. Other active end-stage disease (e.g., late stage cancer or pulmonary disease) 7. Actively receiving cancer treatment 8. Pregnant |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Minneapolis Heart Institute Foundation | Academy of Nutrition and Dietetics |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Blood Pressure (Calibrated Cuff Measurement- Average of 3 Readings) | The count of participants represents the number of individuals meeting blood pressure less than 140/90 at follow up | 1 year | |
| Other | Tobacco Use (Self-reported Questionnaire) | The count of participants represents those not using tobacco at follow up | 1 year | |
| Other | Statin Use (as Noted in EMR) | The count of participants represents those taking a statin as indicated at follow up | 1 year | |
| Other | Aspirin Use (as Noted in EMR) | The count of participants represents taking aspirin as indicated at follow up | 1 year | |
| Primary | A1c (Laboratory Assessment) | The count of participants represents the number of individuals meeting A1c less than 8% at follow up | 1 year |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |